World Wires · story 5628 · unverified · 1 source(s)

Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price

Liminatus Pharma regained compliance with the Nasdaq minimum bid price rule.

Open in the desk

Coverage

• Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price GlobeNewswire: public companies · tier D · clear net · 2026-09-29 13:00 UTC

What this site indexes